These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 10804012)

  • 1. Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers.
    Waltregny D; Bellahcène A; de Leval X; Florkin B; Weidle U; Castronovo V
    J Bone Miner Res; 2000 May; 15(5):834-43. PubMed ID: 10804012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development.
    Bellahcene A; Kroll M; Liebens F; Castronovo V
    J Bone Miner Res; 1996 May; 11(5):665-70. PubMed ID: 9157781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.
    Diel IJ; Solomayer EF; Seibel MJ; Pfeilschifter J; Maisenbacher H; Gollan C; Pecherstorfer M; Conradi R; Kehr G; Boehm E; Armbruster FP; Bastert G
    Clin Cancer Res; 1999 Dec; 5(12):3914-9. PubMed ID: 10632320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells.
    Gordon JA; Sodek J; Hunter GK; Goldberg HA
    J Cell Biochem; 2009 Aug; 107(6):1118-28. PubMed ID: 19492334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of bone matrix proteins in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases.
    Bellahcène A; Castronovo V
    Bull Cancer; 1997 Jan; 84(1):17-24. PubMed ID: 9180854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model.
    Zhang JH; Tang J; Wang J; Ma W; Zheng W; Yoneda T; Chen J
    Int J Oncol; 2003 Oct; 23(4):1043-8. PubMed ID: 12963984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer.
    Bobinac D; Marić I; Zoricić S; Spanjol J; Dordević G; Mustać E; Fuckar Z
    Croat Med J; 2005 Jun; 46(3):389-96. PubMed ID: 15861517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CREB-1 and AP-1 transcription factors JunD and Fra-2 regulate bone sialoprotein gene expression in human breast cancer cells.
    Detry C; Lamour V; Castronovo V; Bellahcène A
    Bone; 2008 Feb; 42(2):422-31. PubMed ID: 18088579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study.
    Papotti M; Kalebic T; Volante M; Chiusa L; Bacillo E; Cappia S; Lausi P; Novello S; Borasio P; Scagliotti GV
    J Clin Oncol; 2006 Oct; 24(30):4818-24. PubMed ID: 17050866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of bone sialoprotein, a bone matrix protein, in human breast cancer.
    Bellahcène A; Merville MP; Castronovo V
    Cancer Res; 1994 Jun; 54(11):2823-6. PubMed ID: 8187059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate stem cell antigen is overexpressed in prostate cancer metastases.
    Lam JS; Yamashiro J; Shintaku IP; Vessella RL; Jenkins RB; Horvath S; Said JW; Reiter RE
    Clin Cancer Res; 2005 Apr; 11(7):2591-6. PubMed ID: 15814638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of parathyroid hormone-related protein and its receptor in bone metastases from prostate cancer.
    Iddon J; Bundred NJ; Hoyland J; Downey SE; Baird P; Salter D; McMahon R; Freemont AJ
    J Pathol; 2000 Jun; 191(2):170-4. PubMed ID: 10861577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of bone sialoprotein in human breast cancer tissue and cell lines at both protein and messenger ribonucleic acid levels.
    Bellahcène A; Antoine N; Clausse N; Tagliabue E; Fisher LW; Kerr JM; Jarès P; Castronovo V
    Lab Invest; 1996 Aug; 75(2):203-10. PubMed ID: 8765320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of bone morphogenetic proteins in human prostate cancer pathogenesis and development of bone metastases: immunohistochemical study.
    Spanjol J; Djordjević G; Markić D; Klarić M; Fuckar D; Bobinac D
    Coll Antropol; 2010 Apr; 34 Suppl 2():119-25. PubMed ID: 21302710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients.
    Leeming DJ; Koizumi M; Byrjalsen I; Li B; Qvist P; Tankó LB
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):32-8. PubMed ID: 16434583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.
    Sharp JA; Sung V; Slavin J; Thompson EW; Henderson MA
    Lab Invest; 1999 Jul; 79(7):869-77. PubMed ID: 10418827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features of pathologically confirmed metastatic bone tumors--a report of 390 cases].
    Xu DL; Zhang XT; Wang GH; Li FB; Hu JY
    Ai Zheng; 2005 Nov; 24(11):1404-7. PubMed ID: 16552972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the calcium receptor in human breast cancer--a potential new marker predicting the risk of bone metastases.
    Mihai R; Stevens J; McKinney C; Ibrahim NB
    Eur J Surg Oncol; 2006 Jun; 32(5):511-5. PubMed ID: 16564154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy.
    Zissimopoulos A; Stellos K; Matthaios D; Petrakis G; Parmenopoulou V; Babatsikou F; Matthaiou E; Theodosiadou E; Hountis P; Koutis C
    J BUON; 2009; 14(3):463-72. PubMed ID: 19810140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.